Search
Brolamfetamine
go.drugbank.com/drugs/DB01484ExperimentalIllicitCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeDisoxaril
go.drugbank.com/drugs/DB08726ExperimentalThis compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
Phenoperidine
go.drugbank.com/drugs/DB13605ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeRO7284755
go.drugbank.com/drugs/DB17527InvestigationalRO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And
Synonyms: RO 7284755, RO-7284755D-fluoromethyltyrosine F-18
go.drugbank.com/drugs/DB15296InvestigationalNCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small
Gemilukast
go.drugbank.com/drugs/DB19882InvestigationalGemilukast is under investigation in clinical trial NCT01536041 (A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients). Gemilukast has a monoisotopic molecular weight of 601.26 Da.
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
go.drugbank.com/drugs/DB08721ExperimentalThis compound belongs to the phenol ethers.
5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole
go.drugbank.com/drugs/DB08728ExperimentalThis compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.